$KITT
Nauticus Robotics, Inc. Stock $kitt

$kitt Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000184982024000029 Filed on April 10, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$501.7K	$1.064M	$6.606M
YoY Change	-55.53%	-67.07%	-42.23%
Cost Of Revenue	$2.875M	$4.445M	$11.93M
YoY Change	51.29%	22.11%	0.55%
Gross Profit	-$2.374M	-$3.381M	-$5.323M
YoY Change	207.28%	705.02%	1140.98%
Gross Profit Margin	-473.12%	-317.89%	-80.57%
Selling, General & Admin	$3.227M	$3.337M	$20.81M
YoY Change	-41.96%	-46.87%	53.5%
% of Gross Profit
Research & Development	$0.00	$414.7K	$1.400M
YoY Change	-100.0%	48.1%	-41.12%
% of Gross Profit
Depreciation & Amortization	$411.6K	$242.4K	$729.4K
YoY Change	585.97%	61.57%	41.1%
% of Gross Profit
Operating Expenses	$0.00	$3.994M	$22.94M
YoY Change	-100.0%	-40.48%	865.27%
Operating Profit	-$6.013M	-$7.375M	-$28.27M
YoY Change	-12.47%	3.43%	53.79%
Interest Expense	-$3.674M	-$1.399M	-$8.820M
YoY Change	138.55%	111.95%	137.74%
% of Operating Profit
Other Income/Expense, Net	$639.2K	-$3.934M	$13.23M
YoY Change	-97.68%	794.01%	33.9%
Pretax Income	-$5.373M	-$39.54M	-$50.69M
YoY Change	-126.0%	381.05%	79.36%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$5.373M	-$39.54M	-$50.69M
YoY Change	-125.99%	380.87%	79.35%
Net Earnings / Revenue	-1071.01%	-3717.81%	-767.24%
Basic Earnings Per Share	-$2.75		-$1.24
Diluted Earnings Per Share	-$2.75	-$0.93	-$1.24
COMMON SHARES
Basic Shares Outstanding	62.09M shares	50.04M shares	40.94M shares
Diluted Shares Outstanding	1.951M shares		40.94M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.123M	$753.4K	$753.4K
YoY Change	84.61%	-96.68%	-96.68%
Cash & Equivalents	$8.123M	$753.4K	$753.4K
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$490.4K	$6.057M	$5.362M
YoY Change	814.88%	123.48%	1.16%
Inventory	$2.218M	$2.199M	$2.199M
Prepaid Expenses	$1.283M	$1.889M
Receivables	$176.5K	$212.4K	$212.4K
Other Receivables	$0.00	$0.00	$695.0K
Total Short-Term Assets	$13.11M	$9.221M	$9.221M
YoY Change	-48.02%	-75.05%	-75.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.50M	$16.74M	$16.74M
YoY Change	-24.25%	10.37%	8.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$204.3K	$187.5K	$187.5K
YoY Change	57.92%	20.61%	-6.24%
Total Long-Term Assets	$18.09M	$16.93M	$16.93M
YoY Change	-22.37%	8.23%	8.51%
TOTAL ASSETS
Total Short-Term Assets	$13.11M	$9.221M	$9.221M
Total Long-Term Assets	$18.09M	$16.93M	$16.93M
Total Assets	$31.20M	$26.15M	$26.15M
YoY Change	-35.71%	-50.29%	-50.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.594M	$7.035M	$7.035M
YoY Change	-2.4%	2068.2%	2245.15%
Accrued Expenses	$5.213M	$7.584M	$7.584M
YoY Change	-28.69%	141.3%	110.66%
Deferred Revenue	$457.9K	$2.768M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.69M	$17.39M	$17.39M
YoY Change	-13.86%	348.4%	345.83%
LONG-TERM LIABILITIES
Long-Term Debt	$46.64M	$31.60M	$31.60M
YoY Change	162.04%	98.45%	98.73%
Other Long-Term Liabilities	$2.228M	$18.95M	$18.95M
YoY Change	-61.89%		-42.22%
Total Long-Term Liabilities	$48.87M	$50.55M	$50.55M
YoY Change	106.67%	217.47%	3.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.69M	$17.39M	$17.39M
Total Long-Term Liabilities	$48.87M	$50.55M	$50.55M
Total Liabilities	$60.56M	$67.94M	$67.94M
YoY Change	58.51%	29.22%	29.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$123.8M	-$118.8M
YoY Change	100.99%	74.42%
Common Stock	$413.00	$5.004K
YoY Change	-91.38%	-98.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$29.36M	-$41.79M	-$41.79M
YoY Change
Total Liabilities & Shareholders Equity	$31.20M	$26.15M	$26.15M
YoY Change	-35.71%	-50.29%	-50.29%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$5.373M	-$39.54M	-$50.69M
YoY Change	-125.99%	380.87%	79.35%
Depreciation, Depletion And Amortization	$411.6K	$242.4K	$729.4K
YoY Change	585.97%	61.57%	41.1%
Cash From Operating Activities	-$8.391M	-$5.252M	-$21.69M
YoY Change	102.68%	-8.5%	-41.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$6.100K	-$808.6K	-$6.594M
YoY Change	-100.13%	-93.48%	-65.67%
Cash From Investing Activities	$6.100K	-$808.6K	-$6.594M
YoY Change	-100.13%	-93.48%	-65.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$421.2K
YoY Change			-98.64%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.32M	42.50K	11.25M
YoY Change	1564.59%		-78.9%
NET CHANGE
Cash From Operating Activities	-8.391M	-5.252M	-21.69M
Cash From Investing Activities	6.100K	-808.6K	-6.594M
Cash From Financing Activities	10.32M	42.50K	11.25M
Net Change In Cash	1.936M	-6.018M	-17.03M
YoY Change	-123.81%	-66.82%	438.07%
FREE CASH FLOW
Cash From Operating Activities	-$8.391M	-$5.252M	-$21.69M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001849820
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ServiceMember
CY2023	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ServiceMember
CY2023	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2023#ServiceMember
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023	kitt	Derivative Instrument Contingent Consideration Liability Earnout Period Days Prior To Redemption DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodDaysPriorToRedemption	3	businessday
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40611
CY2023	dei	Entity Registrant Name EntityRegistrantName	NAUTICUS ROBOTICS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1699753
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	17146 FEATHERCRAFT LANE
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 450
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	WEBSTER
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77598
CY2023	dei	City Area Code CityAreaCode	(281)
CY2023	dei	Local Phone Number LocalPhoneNumber	942-9069
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	21885108	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	62089911	shares
CY2023	dei	Auditor Firm AuditorFirmId	726
CY2023	dei	Auditor Name AuditorName	Whitley Penn LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023Q4	us-gaap	Cash Cash	753398	usd
CY2022Q4	us-gaap	Cash Cash	17787159	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	201822	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	250375	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	4959263	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	212428	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1622434	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2198797	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6666912	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	573895	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1889218	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5046599	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1025214	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	56410	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	2940254	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	0	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9221131	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	36963047	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15904845	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15167367	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	834972	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317208	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	187527	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	155490	usd
CY2023Q4	us-gaap	Assets Assets	26148475	usd
CY2022Q4	us-gaap	Assets Assets	52603112	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7035450	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	324484	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7339099	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3142977	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2767913	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	244774	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	410158	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17387236	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3877619	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	18376180	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	32688342	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	574260	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87214	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	31597649	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	15922118	usd
CY2023Q4	us-gaap	Liabilities Liabilities	67935325	usd
CY2022Q4	us-gaap	Liabilities Liabilities	52575293	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	625000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	625000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50035824	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47250771	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50035824	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47250771	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	5004	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4725	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	76999849	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	68128196	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-118791703	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68105102	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-41786850	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27819	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26148475	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52603112	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6606352	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11434959	usd
CY2023	kitt	Cost Of Revenue Excluding Loss On Contracts CostOfRevenueExcludingLossOnContracts	11928931	usd
CY2022	kitt	Cost Of Revenue Excluding Loss On Contracts CostOfRevenueExcludingLossOnContracts	11863862	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	729412	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1399560	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2376912	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18271832	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15040603	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	1476636	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	15962	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	25354791	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Loss On Contracts LossOnContracts	2542913	usd
CY2022	us-gaap	Loss On Contracts LossOnContracts	0	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	61704075	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-55097723	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-18379329	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-627580	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33247	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-453162	usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-44020	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	260615	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-590266	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14902427	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	6461087	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8776277	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3714017	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4411122	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9881242	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-50686601	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28260571	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.75
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.75
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40943444	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40943444	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18982139	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18982139	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27819	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4427073	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	421175	usd
CY2023	kitt	Stock Issued During Period Exercise Of Warrants StockIssuedDuringPeriodExerciseOfWarrants	338055	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3685629	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-41786850	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6611457	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	14548914	usd
CY2022	kitt	Conversion Of Series A Preferred Stock In Connection With Reverse Recapitalization ConversionOfSeriesAPreferredStockInConnectionWithReverseRecapitalization	0	usd
CY2022	kitt	Conversion Of Series B Preferred Stock In Connection With Reverse Recapitalization ConversionOfSeriesBPreferredStockInConnectionWithReverseRecapitalization	0	usd
CY2022	kitt	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	-669242	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2022	kitt	Stock Issued During Period Value Of Common Stock For Pipe Investment StockIssuedDuringPeriodValueOfCommonStockForPIPEInvestment	31000000	usd
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	12582000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28260571	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27819	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28260571	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	729412	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	516949	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4033330	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1342062	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	52092	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	27608	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	4427073	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2602175	usd
CY2023	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	590266	usd
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	0	usd
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-14902427	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	6461087	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	346714	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	196555	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	378118	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	25354791	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	kitt	Settlement Of Liquidated Damages With Common Stock SettlementOfLiquidatedDamagesWithCommonStock	3685629	usd
CY2022	kitt	Settlement Of Liquidated Damages With Common Stock SettlementOfLiquidatedDamagesWithCommonStock	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-82604	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-453162	usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	40737	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1410006	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	828298	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11581138	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6666912	usd
CY2023	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	-573895	usd
CY2022	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	-319480	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2707815	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4902797	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8241528	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7731279	usd
CY2023	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	2767913	usd
CY2022	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	0	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-338979	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-323434	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21687926	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37274983	usd
CY2023	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	11633153	usd
CY2022	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	14247005	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	38704	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	5000000	usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	4959263	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6594449	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19206268	usd
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	11096884	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	2000000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	607500	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	338055	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	421175	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	17850333	usd
CY2023	kitt	Proceeds From Reverse Recapitalization With Cleantech Acquisition Corp Net ProceedsFromReverseRecapitalizationWithCleantechAcquisitionCorpNet	0	usd
CY2022	kitt	Proceeds From Reverse Recapitalization With Cleantech Acquisition Corp Net ProceedsFromReverseRecapitalizationWithCleantechAcquisitionCorpNet	14947876	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31000000	usd
CY2023	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	35800000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	12582000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11248614	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53315543	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17033761	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3165708	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17787159	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20952867	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	753398	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17787159	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1006993	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2719947	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	kitt	Capital Expenditures Included In Accounts Payable CapitalExpendituresIncludedInAccountsPayable	849951	usd
CY2022	kitt	Capital Expenditures Included In Accounts Payable CapitalExpendituresIncludedInAccountsPayable	241679	usd
CY2023	kitt	Operating Leases At Inception OperatingLeasesAtInception	2016931	usd
CY2022	kitt	Operating Leases At Inception OperatingLeasesAtInception	0	usd
CY2023	kitt	Transfer From Inventories To Property And Equipment TransferFromInventoriesToPropertyAndEquipment	15904411	usd
CY2022	kitt	Transfer From Inventories To Property And Equipment TransferFromInventoriesToPropertyAndEquipment	0	usd
CY2023	kitt	Transfer From Property And Equipment To Assets Held For Sale TransferFromPropertyAndEquipmentToAssetsHeldForSale	2940524	usd
CY2022	kitt	Transfer From Property And Equipment To Assets Held For Sale TransferFromPropertyAndEquipmentToAssetsHeldForSale	0	usd
CY2023	kitt	Conversion Of Convertible Debt And Accrued Interest Expense To Common Stock ConversionOfConvertibleDebtAndAccruedInterestExpenseToCommonStock	0	usd
CY2022	kitt	Conversion Of Convertible Debt And Accrued Interest Expense To Common Stock ConversionOfConvertibleDebtAndAccruedInterestExpenseToCommonStock	14548914	usd
CY2023	kitt	Private And Public Warrant Liabilities Assumed In Reverse Recapitalization PrivateAndPublicWarrantLiabilitiesAssumedInReverseRecapitalization	0	usd
CY2022	kitt	Private And Public Warrant Liabilities Assumed In Reverse Recapitalization PrivateAndPublicWarrantLiabilitiesAssumedInReverseRecapitalization	5278145	usd
CY2023	kitt	Fair Value Of Spa Warrants At Issuance FairValueOfSPAWarrantsAtIssuance	0	usd
CY2022	kitt	Fair Value Of Spa Warrants At Issuance FairValueOfSPAWarrantsAtIssuance	20949110	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	Description of the Business<div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nauticus Robotics, Inc. (the “Company”, “our”, "us" or “we”) develops autonomous robots for the ocean industries. We were initially incorporated as CleanTech Acquisition Corp. (“CLAQ”) under the laws of the State of Delaware on June 18, 2020. The Company’s principal corporate offices are located in Webster, Texas. Nauticus’ robotic systems and services are designed to address both commercial and government-facing customers. Nauticus Robotics, Inc. develops autonomous robots for the ocean industries. Autonomy requires the extensive use of sensors, artificial intelligence, and effective algorithms for perception and decision allowing the robot to adapt to changing environments. The company’s business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus has designed and is currently testing and certifying a new generation of vehicles to reduce operational cost and gather data to maintain and operate a wide variety of subsea infrastructure. Besides a standalone service offering and forward-facing products, Nauticus’ approach to ocean robotics has also resulted in the development of a range of technology products for retrofit/upgrading legacy systems and other third-party vehicle platforms. Nauticus’ services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combination </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On September 9, 2022 (the “Closing Date”), Nauticus Robotics, Inc. consummated its business combination pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement,” and together with the other agreements and transactions contemplated by the Merger Agreement, the “Business Combination”) with CleanTech Merger Sub, Inc., a wholly owned subsidiary of CLAQ (“Merger Sub”), and Nauticus Robotics, Inc., a Texas corporation (prior to the Closing Date, “Nauticus Robotics Holdings, Inc.”). Pursuant to the terms of the Merger Agreement, a business combination between CLAQ and Nauticus Robotics Holdings, Inc. was affected through the merger of Merger Sub with and into Nauticus Robotics Holdings, Inc., with Nauticus Robotics Holdings, Inc. surviving the merger as a wholly owned subsidiary of CLAQ. On the Closing Date, CLAQ was renamed “Nauticus Robotics, Inc.” and the previous Nauticus Robotics, Inc. was renamed “Nauticus Robotics Holdings, Inc.”.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing, among other things, (a) each share of Nauticus Preferred Stock, par value $0.01 per share, that was issued and outstanding immediately prior to the closing converted into shares of Nauticus Common stock, par value $0.01 per share, (“Nauticus Preferred Stock Conversion”); (b) each of Nauticus Robotic Holdings, Inc.’s unsecured convertible note obligations outstanding was converted into shares of Nauticus Common Stock in accordance with the terms of each such Nauticus Convertible Note; and (c) each share of Nauticus Common Stock (including shares of Nauticus Common Stock outstanding as a result of the Nauticus Preferred Stock Conversion and Nauticus Convertible Notes Conversion) was converted into the right to receive (i) the per share merger consideration and (ii) Earnout Shares.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued at closing is summarized as follows (i) an aggregate of 36,650,778 shares of Common Stock, par value $0.0001 (the “Common Stock” of CLAQ prior to the Closing, and the Common Stock of Nauticus following the Closing) shares were issued to holders of Nauticus Common Stock in the Business Combination (ii) the right to receive 7,499,993 additional shares of Common Stock held in escrow pursuant to the terms of the Merger Agreement and as further described below (such additional escrowed shares, the “Earnout Shares”) and (iii) the issuance of 3,100,000 shares of Common Stock for the Equity Financing (as described below). An aggregate of 47,250,771 shares of Common Stock (inclusive of the Earnout Shares) was issued after the Business Combination.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Former holders of Nauticus Common Stock are entitled to receive their pro rata share of up to 7,499,993 additional shares of Common Stock (the “Earnout Shares”) held in escrow. The Earnout Shares will be released upon occurrence of the following (each, a “Triggering Event”):</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">one-half of the Earnout Shares will be released if, within a 5-year period, the volume-weighted average price of our Common Stock equals or exceeds $15.00 per share over any 20 trading days within a 30-day trading period;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">one-quarter of the Earnout Shares will be released if, within a 5-year period, the volume-weighted average price of our Common Stock equals or exceeds $17.50 per share over any 20 trading days within a 30-day trading period; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">one-quarter of the Earnout Shares will be released if, within a 5-year period, the volume-weighted average price of our Common Stock equals or exceeds $20.00 per share over any 20 trading days within a 30-day trading period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At closing, we received proceeds from Private Investment in a Public Entity subscribers (“PIPE Investment”) consisting of:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the issuance of 3,100,000 shares of Common Stock, for a purchase price of $10.00 per share and an aggregate purchase price of $31 million (the “Equity Financing”), and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the issuance of secured Debentures with warrants having an aggregate principal amount of $36,530,320 (the “Debentures”) pursuant to a securities purchase agreement with certain investors providing net proceeds of $35,800,000 inclusive of a 2% original issue discount. The fair value of the SPA Warrants was estimated to be $20,949,110 using a Monte Carlo valuation model incorporating future projections of the various potential outcomes and any exercise price adjustments based on future financing events. The Debentures are convertible into 2,922,425 shares of Common Stock and associated warrants for an additional 2,922,425 shares with an exercise price equal to $20 per share, subject to adjustment (“SPA Warrants”). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination was accounted for as a reverse recapitalization under generally accepted accounting principles in the United States (“GAAP”). Nauticus Robotics Holdings Inc. was determined to be the accounting acquirer and CLAQ was treated as the acquired company for financial reporting purposes. Accordingly, the financial statements of the combined company represent a continuation of the financial statements of Nauticus Robotics Holdings Inc. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2022, the Company received from the Business Combination with CLAQ net cash of $14,947,875. The Company also assumed $30,157 in prepaids, $14,796,942 in accounts payable and accrued liabilities, $850,333 in notes payable and net equity of $(669,243).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLAQ’s net cash at the Closing Date totaled $14,947,875. This amount, together with proceeds of the PIPE Investment, were available to repay certain indebtedness, transaction costs and for general corporate purposes.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred $12,582,000 in direct and incremental costs associated with the Equity Financing, which primarily consisted of investment banking, legal, accounting, and other professional fees.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2023, the Company and ATW Special Situations I LLC, as the purchaser, entered into a Securities Purchase Agreement (the “PIPE SPA”), pursuant to which the purchaser agreed to purchase up to an aggregate of $5,000 of the shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”), at a $2 per share purchase price. The sale of these shares of Common Stock was subject to the terms and conditions set forth in the PIPE SPA and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 promulgated thereunder as a transaction by an issuer not involving a public offering. As a result of the sale of shares under the PIPE SPA, the conversion prices under the warrants and debentures issued pursuant to the Securities Purchase Agreement (as defined below) were reset to $2 pursuant to their terms, removing future dilutive effects pursuant to the “ratchet” provisions of such warrants and debentures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred recurring losses each year since its inception. The Company continues to develop its principal products and conduct research and development activities. Supply chain disruptions instigated production delays and have continued to impact the Company’s ability to deploy its products and realize rental or product sale revenues. Currently, the Company does not generate sufficient revenue to cover operating expenses, working capital and capital expenditures. The Company has embarked on cost-cutting measures to continue to preserve cash. </span><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may require additional liquidity to continue its operations over the next twelve months to sufficiently alleviate or mitigate the conditions and events noted above, which a current investor has committed to the Company. The Company believes with this investor support that there will be sufficient resources to continue as a going concern for at least one year from the date that the consolidated financial statements contained in this Form 10-K are issued.</span></div>
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	7499993	shares
CY2022Q3	kitt	Additional Share Of Common Stock AdditionalShareOfCommonStock	7499993	shares
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	3100000	shares
CY2022Q3	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	10.00
CY2022Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	31000000	usd
CY2022Q3	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	14947875	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	30157	usd
CY2022Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	14796942	usd
CY2022Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	850333	usd
CY2022Q3	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-669243	usd
CY2022Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	14947875	usd
CY2022Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	12582000	usd
CY2023Q4	kitt	Sale Of Stock Maximum Amount Of Shares Authorized To Be Sold SaleOfStockMaximumAmountOfSharesAuthorizedToBeSold	5000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2
CY2023	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) estimates of future costs to complete customer contracts recognized over time, (ii) valuation allowances for deferred income tax assets, (iii) valuation of stock-based compensation awards and (iv) the valuation of conversion options, warrants and earnouts. Actual results could differ from those estimates.
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	201822	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	250375	usd
CY2023Q3	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	150000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	4959263	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	5000000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2040	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9963	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9963	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	25354791	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	898335	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1499030	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1300462	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5167882	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	2198797	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	6666912	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-44020	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	260615	usd
CY2022Q3	kitt	Derivative Instrument Contingent Consideration Liability Earnout Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriod	P5Y
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1515446	usd
CY2023	kitt	Interest Costs Capitalized Inventory InterestCostsCapitalizedInventory	354162	usd
CY2023	kitt	Inventory Costs Capitalized Property Plant And Equipment InventoryCostsCapitalizedPropertyPlantAndEquipment	1161284	usd
CY2022	kitt	Interest Costs Capitalized Inventory InterestCostsCapitalizedInventory	804000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Financial statements presented for prior periods include reclassifications that were made to conform to the current year presentation. There was no material impact to the consolidated financial statements for these changes.
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6606352	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11434959	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	212428	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1622434	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9963	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2040	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9963	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	573895	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	0	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2767913	usd
CY2023	us-gaap	Loss On Contracts LossOnContracts	2542913	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	600000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	600000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	600000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	440091	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	2454298	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1282703	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2392978	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	166424	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	199323	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1889218	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5046599	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	695000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	330214	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	56410	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1025214	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	56410	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2035034	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2003341	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15904845	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15167367	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	25354791	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	2940254	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-82604	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	618630	usd
CY2022Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	1501736	usd
CY2023Q4	kitt	Accrued Severance Current AccruedSeveranceCurrent	1375000	usd
CY2022Q4	kitt	Accrued Severance Current AccruedSeveranceCurrent	0	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1355721	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	794021	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	876150	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	590936	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	885292	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	171660	usd
CY2023Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	250000	usd
CY2022Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	0	usd
CY2023Q4	kitt	Asset Held For Sale Not Part Of Disposal Group Liability Current AssetHeldForSaleNotPartOfDisposalGroupLiabilityCurrent	1158609	usd
CY2022Q4	kitt	Asset Held For Sale Not Part Of Disposal Group Liability Current AssetHeldForSaleNotPartOfDisposalGroupLiabilityCurrent	0	usd
CY2023Q4	kitt	Operating Lease Liability Accrued Termination Costs Current OperatingLeaseLiabilityAccruedTerminationCostsCurrent	657000	usd
CY2022Q4	kitt	Operating Lease Liability Accrued Termination Costs Current OperatingLeaseLiabilityAccruedTerminationCostsCurrent	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	162697	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	84624	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7339099	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3142977	usd
CY2023Q4	kitt	Asset Held For Sale Not Part Of Disposal Group Liability Current AssetHeldForSaleNotPartOfDisposalGroupLiabilityCurrent	1158609	usd
CY2023Q2	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	575602	usd
CY2023Q4	kitt	Convertible Secured Debentures ConvertibleSecuredDebentures	36530320	usd
CY2022Q4	kitt	Convertible Secured Debentures ConvertibleSecuredDebentures	36530320	usd
CY2023Q4	kitt	Convertible Senior Secured Term Loan ConvertibleSeniorSecuredTermLoan	12295000	usd
CY2022Q4	kitt	Convertible Senior Secured Term Loan ConvertibleSeniorSecuredTermLoan	0	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	48825320	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	36530320	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	16593357	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	20608202	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	661922	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	usd
CY2023Q4	kitt	Debt Instrument Exit Fee Provisions DebtInstrumentExitFeeProvisions	27608	usd
CY2022Q4	kitt	Debt Instrument Exit Fee Provisions DebtInstrumentExitFeeProvisions	0	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	31597649	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15922118	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.02
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2922425	shares
CY2022Q3	kitt	Inclusive Proceeds InclusiveProceeds	35800000	usd
CY2022Q3	kitt	Fair Value Debenture Warrants FairValueDebentureWarrants	20949110	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	21679716	usd
CY2022Q3	kitt	Warrant Exercisable Share WarrantExercisableShare	2922425	shares
CY2022Q3	kitt	Exercisable Initially Par Share ExercisableInitiallyParShare	20.00
CY2022Q3	kitt	Exercisable Initially Par Share ExercisableInitiallyParShare	20.00
CY2022Q3	kitt	Exercisable Initially Par Share ExercisableInitiallyParShare	20.00
CY2023Q4	kitt	Convertible Secured Debentures Net ConvertibleSecuredDebenturesNet	19936963	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	16593357	usd
CY2023	us-gaap	Interest Income Debt Securities Trading Operating InterestIncomeDebtSecuritiesTradingOperating	4014844	usd
CY2022	us-gaap	Interest Income Debt Securities Trading Operating InterestIncomeDebtSecuritiesTradingOperating	1071228	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	5000000	usd
CY2023Q3	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.125
CY2023Q3	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	125000	usd
CY2023Q3	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	1
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.0001
CY2023Q4	kitt	Convertible Senior Secured Term Loan ConvertibleSeniorSecuredTermLoan	12295000	usd
CY2023Q4	kitt	Convertible Senior Secured Term Loan Net ConvertibleSeniorSecuredTermLoanNet	11660686	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	661922	usd
CY2023Q4	kitt	Notes Payable Exit Fee NotesPayableExitFee	27608	usd
CY2023	kitt	Debt Instrument Exit Fee Expense DebtInstrumentExitFeeExpense	27608	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	52092	usd
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2023Q2	kitt	Lessee Operating Lease Abatement Period LesseeOperatingLeaseAbatementPeriod	P23M
CY2023Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.15
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-453162	usd
CY2023Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2023Q3	kitt	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	2	option
CY2023Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.15
CY2023Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2023Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.15
CY2023	kitt	Fixed Lease Cost FixedLeaseCost	567380	usd
CY2022	kitt	Fixed Lease Cost FixedLeaseCost	275763	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	195637	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	178032	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	763017	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	453795	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	58379	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2023	us-gaap	Lease Cost LeaseCost	821396	usd
CY2022	us-gaap	Lease Cost LeaseCost	453795	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	338979	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	323434	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	834972	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317208	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	244774	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	410158	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	574260	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87214	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	819034	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	497372	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y8M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.143
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	243350	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	191506	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	186641	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	186641	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	139168	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	325072	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1272378	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	453344	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	819034	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-50686601	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-28260571	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10644186	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5934720	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1251583	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	193421	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	510514	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	usd
CY2023	kitt	Federal Return To Accrual FederalReturnToAccrual	-13141	usd
CY2022	kitt	Federal Return To Accrual FederalReturnToAccrual	0	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	8895230	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5741299	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	kitt	Effective Tax Rate EffectiveTaxRate	0.0000
CY2022	kitt	Effective Tax Rate EffectiveTaxRate	0.0000
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3377201	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	113135	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	267236	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	758306	usd
CY2023Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	1356828	usd
CY2022Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	1356828	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15627776	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9666591	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1441159	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1426116	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	614299	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	449626	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	199680	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	109616	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22884179	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13880218	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22654106	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13758875	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	230073	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	121343	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	54729	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	54729	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	175344	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	66614	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	230073	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	121343	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	74400000	usd
CY2023	kitt	Expired Amount ExpiredAmount	646000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50035824	shares
CY2023Q4	kitt	Sale Of Stock Maximum Amount Of Shares Authorized To Be Sold SaleOfStockMaximumAmountOfSharesAuthorizedToBeSold	5000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.95
CY2022Q3	us-gaap	Shares Issued SharesIssued	7499993	shares
CY2022Q3	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	4957366	usd
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3100000	shares
CY2022Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	10.00
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	31000000	usd
CY2023	kitt	Private Warrants Shares PrivateWarrantsShares	8624991	shares
CY2023	kitt	Class Of Warrant Or Right Registration Statement Required Effective Period Within Consummation Of Business Combination ClassOfWarrantOrRightRegistrationStatementRequiredEffectivePeriodWithinConsummationOfBusinessCombination	P120D
CY2023	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.01
CY2023	kitt	Derivative Instrument Contingent Consideration Liability Earnout Period Minimum Prior Written Notice Required Of Redemption DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodMinimumPriorWrittenNoticeRequiredOfRedemption	30	d
CY2023	kitt	Common Stock Exceeds Price CommonStockExceedsPrice	16.50
CY2023	kitt	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	tradingday
CY2023	kitt	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	tradingday
CY2023	kitt	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	tradingday
CY2023	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	11.50
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	380531	usd
CY2023Q4	kitt	Warrants And Rights Outstanding Remaining Term WarrantsAndRightsOutstandingRemainingTerm	P3Y8M8D
CY2023	kitt	Class Of Warrant Or Right Registration Statement Period Required Before Closing ClassOfWarrantOrRightRegistrationStatementPeriodRequiredBeforeClosing	P15D
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.286
CY2023Q3	us-gaap	Interest Expense InterestExpense	4320690	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.95
CY2023Q3	kitt	Agreed Price Per Share AgreedPricePerShare	2.286
CY2023Q2	kitt	Warrant Exercisable Share WarrantExercisableShare	2922425	shares
CY2023Q2	kitt	Aggregate Shares AggregateShares	2922425	shares
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	165713	shares
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	165713	shares
CY2023Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	338055	usd
CY2023Q3	kitt	Convertible Loan Agreement Price Per Share ConvertibleLoanAgreementPricePerShare	6.00
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7528508	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	10525072	shares
CY2023	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	7651662	shares
CY2023	kitt	Business Combination Shares BusinessCombinationShares	279464	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3011247	shares
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	3970266	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	0	shares
CY2023	kitt	Continuous Service Percentage ContinuousServicePercentage	0.25
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	800513	usd
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y8M4D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3506184	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.87
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6554541	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	227837	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.85
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	92040	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.98
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	175060	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.18
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3011247	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.85
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.85
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	9717	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2259124	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.74
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9717	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M24D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y11M19D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.31
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	104985	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	196711	usd
CY2023Q3	kitt	Convertible Loan Agreement Price Per Share ConvertibleLoanAgreementPricePerShare	6.00
CY2023Q3	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	552377	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3011247	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.85
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2259124	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.74
CY2023Q2	kitt	Vested Percentage VestedPercentage	0.51
CY2023Q2	kitt	Aggregate Of Shares AggregateOfShares	619438	shares
CY2023	kitt	Performance Based Restricted Stock Units Earned Percentage PerformanceBasedRestrictedStockUnitsEarnedPercentage	0.50
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3134677	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.73
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1185666	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.97
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	501437	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.31
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1446933	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.60
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2371973	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.51
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.97
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.73
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1132352	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	0	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	818000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	409000	usd
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	342459	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	367796	usd
CY2023	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	29591600	usd
CY2023Q4	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.05
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	165713	shares
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	165713	shares
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	165713	shares
CY2023Q2	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	338039	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-50686601	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-28260571	usd
CY2023	kitt	Deemed Dividend For Earnout Shares Amount DeemedDividendForEarnoutSharesAmount	0	usd
CY2022	kitt	Deemed Dividend For Earnout Shares Amount DeemedDividendForEarnoutSharesAmount	4957366	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-50686601	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-50686601	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33217937	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-33217937	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40943444	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40943444	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18982139	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18982139	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.75
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.75
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	61379046	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35785704	shares
CY2023	kitt	Warrant Liability WarrantLiability	18376180	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	32688341	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-590266	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14902427	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	18376180	usd
CY2023Q4	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	34000000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001849820-24-000029-index-headers.html	Edgar Link	pending
0001849820-24-000029-index.html	Edgar Link	pending
0001849820-24-000029.txt	Edgar Link	pending
0001849820-24-000029-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kitt-20231231.htm	Edgar Link	pending
kitt-20231231.xsd	Edgar Link	pending
kitt-20231231xex231.htm	Edgar Link	pending
kitt-20231231xex311.htm	Edgar Link	pending
kitt-20231231xex312.htm	Edgar Link	pending
kitt-20231231xex321.htm	Edgar Link	pending
kitt-20231231xex322.htm	Edgar Link	pending
kitt-20231231xex48.htm	Edgar Link	pending
kittclawbackpolicy.htm	Edgar Link	pending
kittclawbackpolicy001.jpg	Edgar Link	pending
kittclawbackpolicy002.jpg	Edgar Link	pending
kittclawbackpolicy003.jpg	Edgar Link	pending
kittclawbackpolicy004.jpg	Edgar Link	pending
kittclawbackpolicy005.jpg	Edgar Link	pending
kittclawbackpolicy006.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
kitt-20231231_def.xml	Edgar Link	unprocessable
kitt-20231231_lab.xml	Edgar Link	unprocessable
kitt-20231231_pre.xml	Edgar Link	unprocessable
kitt-20231231_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kitt-20231231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KITT
Nauticus Robotics, Inc. Stock $kitt

2024 Q2 Form 10-K Financial Statement

#000184982024000029 Filed on April 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITT Nauticus Robotics, Inc. Stock $kitt

2024 Q2 Form 10-K Financial Statement

#000184982024000029 Filed on April 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITT
Nauticus Robotics, Inc. Stock $kitt